Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review

Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Agenus Inc (Agenus) is a clinical-stage immuno-oncology company that discovers, develops and commercializes a wide range of immunotherapeutics for the treatment of various types of cancers and infectious diseases. The companys pipeline portfolio encompasses vaccines for glioblastoma, genital herpes and multiple cancer types; vaccine adjuvants for the treatment of shingles and malaria; and checkpoint antibodies targeted at various diseases. The companys technology portfolio includes antibody discovery platform, vaccine platforms and Heat Shock Protein (HSP) platform. The company has collaborations with several pharmaceutical companies such as GSK, Incyte, and Merck. It operates in the US and Europe. Agenus is headquartered in Lexington, Massachusetts, the US.

Agenus Inc Key Recent Developments

Mar 15,2021: Agenus Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
Mar 02,2021: Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
Feb 09,2021: Andy Hurley named Agenus Chief Commercial Officer
Jan 19,2021: Agenus to Participate in B. Riley Securities Oncology Investor Conference
Nov 09,2020: Agenus presents additional clinical responses and novel biomarker data at SITC2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Section 1 - About the Company
Agenus Inc - Key Facts
Agenus Inc - Key Employees
Agenus Inc - Key Employee Biographies
Agenus Inc - Major Products and Services
Agenus Inc - History
Agenus Inc - Company Statement
Agenus Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Agenus Inc - Business Description
Geographical Segment: Rest of the World
Performance
Geographical Segment: United States
Performance
Agenus Inc - Corporate Strategy
Agenus Inc - SWOT Analysis
SWOT Analysis - Overview
Agenus Inc - Strengths
Agenus Inc - Weaknesses
Agenus Inc - Opportunities
Agenus Inc - Threats
Agenus Inc - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Agenus Inc, Recent Deals Summary
Section 5 Companys Recent Developments
Mar 15, 2021: Agenus Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
Mar 02, 2021: Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
Feb 09, 2021: Andy Hurley named Agenus Chief Commercial Officer
Jan 19, 2021: Agenus to Participate in B. Riley Securities Oncology Investor Conference
Nov 09, 2020: Agenus presents additional clinical responses and novel biomarker data at SITC2020
Nov 05, 2020: Dr. Steven ODay named Agenus Chief Medical Officer
Oct 29, 2020: Agenus R&D update & third quarter financial report
Oct 14, 2020: Agenus to present on seven novel programs at SITC 2020
Oct 13, 2020: Susan Hirsch joins Agenus board of directors
Aug 31, 2020: Paul Clark joins Agenus board of directors
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


Agenus Inc, Key Facts
Agenus Inc, Key Employees
Agenus Inc, Key Employee Biographies
Agenus Inc, Major Products and Services
Agenus Inc, History
Agenus Inc, Subsidiaries
Agenus Inc, Key Competitors
Agenus Inc, Ratios based on current share price
Agenus Inc, Annual Ratios
Agenus Inc, Annual Ratios (Cont...1)
Agenus Inc, Interim Ratios
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Agenus Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


Agenus Inc, Performance Chart (2016 - 2020)
Agenus Inc, Ratio Charts
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Agenus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021

Agenus Inc (AGEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Agenus Inc (Agenus) is a clinical-stage immuno-oncology company. It focuses on the development and commercialization of immunotherapeutics for the treatment of diseases in the fields of cancer and infectious diseases.

USD 250 View Report

Agenus Inc (AGEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Agenus Inc (Agenus) is a clinical-stage immuno-oncology company. It focuses on the development and commercialization of immunotherapeutics for the treatment of diseases in the fields of cancer and infectious diseases.

USD 250 View Report

Agenus Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Agenus Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportMarketlines Agenus Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available